Emerging Frontiers and Future Directions in Nanomedicine: A Comprehensive Review

Simple item page
dc.creatorBHAT, RAMDAS
dc.creatorM M, Himasvi
dc.creatorN, Varshini
dc.creatorShabaraya, AR
dc.date.accessioned2026-01-10T19:04:10Z
dc.date.available2026-01-10T19:04:10Z
dc.date.issued2024-03-11
dc.descriptionNanomedicine stands at the forefront of healthcare advancements, leveraging nanotechnology to enhance diagnosis, treatment, and disease prevention. Within this rapidly growing field, nanoparticles exhibit unique traits, such as a notable surface area-to-volume ratio and precise targeting abilities, making them valuable in medical applications. The article delves into diverse types of nanomedicines utilized in the pharmaceutical sector, exploring their potential advantages and examining targeted drug delivery mechanisms. Key breakthroughs, like globally recognized therapies such as Doxil and Abraxane, have emerged from nanomedicine. However, it emphasizes the necessity to address regulatory and ethical considerations to ensure both safety and efficacy. The article sheds light on limitations in targeted drug delivery, including issues like limited drug payload capacity and a lack of specificity, emphasizing the importance of addressing these challenges. Despite hurdles, the future of nanomedicine appears promising, poised to revolutionize personalized medicine, elevate disease detection and treatment, and support tissue regeneration and repair. Integration with artificial intelligence is highlighted as a potential avenue for achieving more precise and efficient drug delivery and disease diagnosis. The article underscores the significance of ongoing investments and collaborations among researchers, healthcare providers, and industry partners to surmount obstacles and unlock the full potential of nanomedicine. In conclusion, nanomedicine stands as a dynamic and promising field with the potential to bring about significant improvements in healthcare outcomes. Keywords: Nanomedicine, Targeted drug delivery system, Treatment, Healthcare, FDA (food and drug administration).en-US
dc.formatapplication/pdf
dc.formattext/xml
dc.identifierhttps://sumathipublications.com/index.php/ijcrpp/article/view/488
dc.identifier.urihttps://repos.sumathipublications.com:8000/handle/123456789/274
dc.languageeng
dc.publisherSumathi Publicationsen-US
dc.relationhttps://sumathipublications.com/index.php/ijcrpp/article/view/488/658
dc.relationhttps://sumathipublications.com/index.php/ijcrpp/article/view/488/659
dc.relation.ispartofInternational Journal of Current Research in Physiology and Pharmacologyen-US
dc.relation.ispartofseriesVolume 8, Issue 1en-US
dc.rightsCopyright (c) 2024 Ramdas Bhat, Himasvi MM, Varshini N, AR SHABARAYAen-US
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0en-US
dc.sourceInternational Journal of Current Research in Physiology and Pharmacology; Volume 8, Issue 1; 2024; 25-32en-US
dc.source2523-6709
dc.source2523-6695
dc.subjectNanomedicineen-US
dc.subjectTargeted drug delivery systemen-US
dc.subjectTreatmenten-US
dc.subjectHealthcareen-US
dc.subjectFDA (food and drug administration)en-US
dc.titleEmerging Frontiers and Future Directions in Nanomedicine: A Comprehensive Reviewen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Files

Collections

International Journal of Current Research in Physiology and Pharmacology (IJCRPP)